REXAHN PHARMACEUTICALS: A YEAR-IN-REVIEW

From a public company merger to the orphan drug designation of one of its leading cancer drug candidates, Rexahn Pharmaceuticals, (RXHN.OB), a clinical stage pharmaceutical company, has much to be proud of as it reflects on 2005 and looks forward to the year ahead. Based in Rockville, Maryland, Rexahn is a pharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer and disorders of the central nervous system.
Genetic Engineering News